Welcome to
On Feet Nation
Global Prostate Cancer Market Size, Share, Growth, Industry Trends and Forecast 2020-2030
The global multiple prostate cancer market is accounted approximate USD 7250.5 million in 2020 and it is expected to reach approximate USD 11477.1 million by 2030 with a CAGR of 4.7% during forecast period.The prostate cancer is the second most common non-cutaneous cancer in men; which is caused by the abnormal growth of tissues in the prostate gland that produces seminal fluid. It is a part of male reproductive system and prevalent in geriatric men over the age of 50 years. The hazards such as geriatric age, family history, and race are responsible for development of these cancers. This is more common among the African-American population than Caucasians in the U.S. The propelled generality of this cancer are due to rise in the geriatric population, disk bound lifestyle of people in developed countries, and incidence of urological disorder at an early age augments. In the last decade, the substantial advances in androgen receptor (AR) targeting in this cancer including enzalutamide, abiraterone acetate, sipuleucel-T, cabazitaxel, and radium-233. Further, the advancement in immunotherapy and radiopharmaceutical-based therapy, although their optimal use in the clinic remains unclear. By targeting the AR with high affinity and impacting its translocation and function within the nucleus and enzalutamide represents a considerable advance over first-generation antiandrogens. Around 1 in 7 men are diagnosed with this cancer, and approximately 1 in 35 men die from this disease as stated by Urology Care Foundation.
Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020120
Market Dynamics and Factors:
Rapidly aging population, growing awareness among people, rising treatment demand and availability of new treatments is one of the major drivers for the growth of the global prostate cancer market. Moreover, increasing awareness of the healthy life among the population, technological innovation in screening and diagnostic tests, increased geriatric population are some of the other factors which will drive the market. The continued uptake of second-generation hormonal agents into metastatic hormone-naive prostate cancer (mHNPC) and non-metastatic castration-resistant prostate cancer (nmCRPC) treatment; where the extended treatment duration will drive overall sales. However, the high cost and side effects of the treatment is responsible to restrain the prostate cancer market growth. Moreover, unmet medical needs and patent expiry of blockbuster molecules are creating immense opportunities for the market growth during forecast timeframe. Further, new product launch and acquisitions of pharmaceutical expenditure with limited number of players are also adopted by leading players. The new therapies along with better treatment facilities and reimbursement policies are considered to be the challenge for prostate cancer market.
Market Segmentation :
Global Prostate Cancer Market – By Type
Hormone Sensitive
Hormone Refractory
Global Prostate Cancer Market – By Diagnosis Technique
Multipara Metric MRI
Prostate-Specific Antigen
Rectal Exam, And Biopsy
Global Prostate Cancer Market – By Distribution Channel
Chemotherapy (Systematic And Regional)
Hormonal Therapy
Targeted Therapy
Radiation Therapy
Immunotherapy
Surgery
Global Prostate Cancer Market – By End-User
Specialty Centre
Hospital & Clinics
Others
Global Prostate Cancer Market – By Geography
North America
U.S.
Canada
Mexico
Europe
U.K.
France
Germany
Italy
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia Pacific
ROW
Latin America
Middle East
Africa
New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020120
Geographic Analysis:
In 2019, North America was accounted approximately 41% market share across the globe. North America is expected to lead the highest growth of the global prostate cancer market, attributed to rising prevalence of disease, world class diagnosis techniques, advent of vaccines such as Sipuleucel-T, and increasing geriatric population in this region. The high investment in research and development (R&D) of prostate cancer and presence of African-American population are other factors which fuelling the prostate cancer market in the U.S. region. Europe is expected to be the second highest region due to health awareness among the population, advanced diagnosis and favourable regulatory environment which is driven by France and Norway. Additionally, Asia pacific is expected to fastest growing market during the forecast period. The rising awareness about the disease, government support with scheme, and increased investments in R&D of immunotherapy and targeted therapies are key factors for boosting the market. Latin America and the Middle East & Africa region are projected to witness substantial growth due to rise in awareness programs by associations and companies over the upcoming years.
Competitive Scenario:
The key players of global prostate cancer markets are Amgen, Inc., Astellas, Inc., AstraZeneca plc, Johnson and Johnson, Sanofi S.A, Bristol Myers Squibb, Bayer AG, Ipsen Group, Tolmar, Inc., Indevus Pharmaceuticals, and Sanpower Group (Dendreon Corporation).
Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020120
How will this Market Intelligence Report Benefit You?
The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.
Exclusive insight into the key trends affecting the Global Prostate Cancer industry, although key threats, opportunities and disruptive technologies that could shape the Global Prostate Cancer Market supply and demand.
The report tracks the leading market players that will shape and impact the Global Prostate Cancer Market most.
The data analysis present in the Global Prostate Cancer Market report is based on the combination of both primary and secondary resources.
The report helps you to understand the real effects of key market drivers or retainers on Global Prostate Cancer Market business.
The 2021 Annual Global Prostate Cancer Market offers:
100+ charts exploring and analysing the Global Prostate Cancer Market from critical angles including retail forecasts, consumer demand, production and more
15+ profiles of top producing states, with highlights of market conditions and retail trends
Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand
Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Prostate Cancer Market type
Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020120
About Us:
Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.
Contact:
Email: [email protected]
For Latest Update Follow Us:
https://www.facebook.com/Decision-Foresight-110793387201935
https://twitter.com/DecisionFs
https://www.linkedin.com/company/decision-foresight/
© 2024 Created by PH the vintage.
Powered by
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation